These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31866415)

  • 1. The interplay of signaling pathway in endothelial cells-matrix stiffness dependency with targeted-therapeutic drugs.
    Vania V; Wang L; Tjakra M; Zhang T; Qiu J; Tan Y; Wang G
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165645. PubMed ID: 31866415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
    Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
    Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin Ameliorates Matrix Stiffness-Mediated Endothelial Monolayer Disruption.
    Lampi MC; Faber CJ; Huynh J; Bordeleau F; Zanotelli MR; Reinhart-King CA
    PLoS One; 2016; 11(1):e0147033. PubMed ID: 26761203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting RhoA/ROCK pathway in pulmonary arterial hypertension.
    Antoniu SA
    Expert Opin Ther Targets; 2012 Apr; 16(4):355-63. PubMed ID: 22449260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could pharmacological curtailment of the RhoA/Rho-kinase pathway reverse the endothelial barrier dysfunction associated with Ebola virus infection?
    Eisa-Beygi S; Wen XY
    Antiviral Res; 2015 Feb; 114():53-6. PubMed ID: 25512227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
    Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
    Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Between Rho(k) and a hard place: the relation between vessel wall stiffness, endothelial contractility, and cardiovascular disease.
    Huveneers S; Daemen MJ; Hordijk PL
    Circ Res; 2015 Feb; 116(5):895-908. PubMed ID: 25722443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin reduces expression of tissue factor through inhibiting RhoA/ROCK pathway to ameliorate atherosclerosis.
    Zhou J; Yin G; Yu T; Zhang Y; Tian X; Xia D; Shi L
    Panminerva Med; 2021 Sep; 63(3):402-403. PubMed ID: 31577094
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension.
    Oka M; Fagan KA; Jones PL; McMurtry IF
    Br J Pharmacol; 2008 Oct; 155(4):444-54. PubMed ID: 18536743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
    Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
    Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of RhoA or Rac1? Mechanism of cholesterol-independent beneficial effects of statins.
    Rikitake Y; Hirata K
    Circ J; 2009 Feb; 73(2):231-2. PubMed ID: 19164861
    [No Abstract]   [Full Text] [Related]  

  • 12. RhoA and ROCK mediate histamine-induced vascular leakage and anaphylactic shock.
    Mikelis CM; Simaan M; Ando K; Fukuhara S; Sakurai A; Amornphimoltham P; Masedunskas A; Weigert R; Chavakis T; Adams RH; Offermanns S; Mochizuki N; Zheng Y; Gutkind JS
    Nat Commun; 2015 Apr; 6():6725. PubMed ID: 25857352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active tissue stiffness modulation controls valve interstitial cell phenotype and osteogenic potential in 3D culture.
    Duan B; Yin Z; Hockaday Kang L; Magin RL; Butcher JT
    Acta Biomater; 2016 May; 36():42-54. PubMed ID: 26947381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
    Kolavennu V; Zeng L; Peng H; Wang Y; Danesh FR
    Diabetes; 2008 Mar; 57(3):714-23. PubMed ID: 18083785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease.
    Zhou Q; Gensch C; Liao JK
    Trends Pharmacol Sci; 2011 Mar; 32(3):167-73. PubMed ID: 21242007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.
    Sawada N; Liao JK
    Antioxid Redox Signal; 2014 Mar; 20(8):1251-67. PubMed ID: 23919640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of statins on endothelial dysfunction and vascular stiffness.
    Dilaveris P; Giannopoulos G; Riga M; Synetos A; Stefanadis C
    Curr Vasc Pharmacol; 2007 Jul; 5(3):227-37. PubMed ID: 17627566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical stiffness augments ligand-dependent progesterone receptor B activation via MEK 1/2 and Rho/ROCK-dependent signaling pathways in uterine fibroid cells.
    Cordeiro Mitchell CN; Islam MS; Afrin S; Brennan J; Psoter KJ; Segars JH
    Fertil Steril; 2021 Jul; 116(1):255-265. PubMed ID: 33676751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidized LDL signals through Rho-GTPase to induce endothelial cell stiffening and promote capillary formation.
    Oh MJ; Zhang C; LeMaster E; Adamos C; Berdyshev E; Bogachkov Y; Kohler EE; Baruah J; Fang Y; Schraufnagel DE; Wary KK; Levitan I
    J Lipid Res; 2016 May; 57(5):791-808. PubMed ID: 26989083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
    Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
    J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.